Interim effectiveness of the updated 2023-2024 COVID-19 vaccines in adults with immunocompromizing conditions
Am J Transplant
.
2024 Apr 25:S1600-6135(24)00282-X.
doi: 10.1016/j.ajt.2024.04.011.
Online ahead of print.
Author
Marcus R Pereira
PMID:
38677653
DOI:
10.1016/j.ajt.2024.04.011
No abstract available